These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

413 related items for PubMed ID: 28040521

  • 1. Bronchodilator Response in FVC Is Larger and More Relevant Than in FEV1 in Severe Airflow Obstruction.
    Quanjer PH, Ruppel GL, Langhammer A, Krishna A, Mertens F, Johannessen A, Menezes AMB, Wehrmeister FC, Perez-Padilla R, Swanney MP, Tan WC, Bourbeau J.
    Chest; 2017 May; 151(5):1088-1098. PubMed ID: 28040521
    [Abstract] [Full Text] [Related]

  • 2. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S, Comellas A, Make BJ, Hersh CP, Bodduluri S, Georgopoulos D, Kim V, Criner GJ, Dransfield MT, Bhatt SP, COPDGene Investigators–Core Units: <italic>Administrative Center</italic>, COPDGene Investigators–Clinical Centers: <italic>Ann Arbor VA</italic>.
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Substantial variation exists in spirometry interpretation practices for airflow obstruction in accredited lung function laboratories across Australia and New Zealand.
    Holt NR, Thompson BR, Miller B, Borg BM.
    Intern Med J; 2019 Jan; 49(1):41-47. PubMed ID: 30043534
    [Abstract] [Full Text] [Related]

  • 5. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y, Lin J, Wang Z, Wang Z, Tan L, Liu S, Huang J, Gao Y, Zheng J.
    Int J Chron Obstruct Pulmon Dis; 2022 Jan; 17():2623-2633. PubMed ID: 36274994
    [Abstract] [Full Text] [Related]

  • 6. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S, Dirican A, Tuna T.
    Int J Chron Obstruct Pulmon Dis; 2016 Jan; 11():2009-15. PubMed ID: 27616884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis.
    Barjaktarevic IZ, Buhr RG, Wang X, Hu S, Couper D, Anderson W, Kanner RE, Paine Iii R, Bhatt SP, Bhakta NR, Arjomandi M, Kaner RJ, Pirozzi CS, Curtis JL, O'Neal WK, Woodruff PG, Han MK, Martinez FJ, Hansel N, Wells JM, Ortega VE, Hoffman EA, Doerschuk CM, Kim V, Dransfield MT, Drummond MB, Bowler R, Criner G, Christenson SA, Ronish B, Peters SP, Krishnan JA, Tashkin DP, Cooper CB, NHLBI SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS).
    Int J Chron Obstruct Pulmon Dis; 2019 Jan; 14():2927-2938. PubMed ID: 31908441
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Improved criterion for assessing lung function reversibility.
    Ward H, Cooper BG, Miller MR.
    Chest; 2015 Oct; 148(4):877-886. PubMed ID: 25879725
    [Abstract] [Full Text] [Related]

  • 11. Measures of bronchodilator response of FEV1, FVC and SVC in a Swedish general population sample aged 50-64 years, the SCAPIS Pilot Study.
    Torén K, Bake B, Olin AC, Engström G, Blomberg A, Vikgren J, Hedner J, Brandberg J, Persson HL, Sköld CM, Rosengren A, Bergström G, Janson C.
    Int J Chron Obstruct Pulmon Dis; 2017 Oct; 12():973-980. PubMed ID: 28356729
    [Abstract] [Full Text] [Related]

  • 12. Bronchodilator reversibility in Australian adults with chronic obstructive pulmonary disease.
    Reid DW, Soltani A, Johns DP, Bish R, Williams TJ, Burns GP, Walters EH.
    Intern Med J; 2003 Dec; 33(12):572-7. PubMed ID: 14656230
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diagnostic value of post-bronchodilator pulmonary function testing to distinguish between stable, moderate to severe COPD and asthma.
    Richter DC, Joubert JR, Nell H, Schuurmans MM, Irusen EM.
    Int J Chron Obstruct Pulmon Dis; 2008 Dec; 3(4):693-9. PubMed ID: 19281083
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD.
    Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, Barr RG, Arjomandi M, Dransfield MB, Peters SP, Dolezal BA, Kim V, Putcha N, Rennard SI, Paine R, Kanner RE, Curtis JL, Bowler RP, Martinez FJ, Hansel NN, Krishnan JA, Woodruff PG, Barjaktarevic IZ, Couper D, Anderson WH, Cooper CB, Subpopulations and Intermediate Outcome Measures in COPD Study Investigators.
    Chest; 2023 Mar; 163(3):502-514. PubMed ID: 36395858
    [Abstract] [Full Text] [Related]

  • 17. Assessing two spirometric criteria of pre-bronchodilator and post-bronchodilator FEV1/FVC ratio in detecting air flow obstruction.
    Waheed Z, Irfan M, Haque AS, Siddiqui NH, Awan S, Syed B, Khan JA.
    J Pak Med Assoc; 2011 Dec; 61(12):1172-5. PubMed ID: 22355960
    [Abstract] [Full Text] [Related]

  • 18. Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio?
    Saint-Pierre M, Ladha J, Berton DC, Reimao G, Castelli G, Marillier M, Bernard AC, O'Donnell DE, Neder JA.
    Chest; 2019 Sep; 156(3):497-506. PubMed ID: 30768928
    [Abstract] [Full Text] [Related]

  • 19. COPD prognosis in relation to diagnostic criteria for airflow obstruction in smokers.
    Akkermans RP, Biermans M, Robberts B, ter Riet G, Jacobs A, van Weel C, Wensing M, Schermer T.
    Eur Respir J; 2014 Jan; 43(1):54-63. PubMed ID: 23563262
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.